• 1
    Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 2709.
  • 2
    Mariani E, Monastero R, Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007; 12: 2335.
  • 3
    Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet 2006; 367: 126270.
  • 4
    Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 2011; 34: 43042.
  • 5
    Fennema-Notestine C, Hagler DJJ, McEvoy LK et al. Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 2009; 30: 323853.
  • 6
    Bylesjö M, Rantalainen M, Nicholson JK, Holmes E, Trygg J. K-OPLS package: kernel-based orthogonal projections to latent structures for prediction and interpretation in feature space. BMC Bioinformatics 2008; 9: 106.
  • 7
    Cuingnet R, Gerardin E, Tessieras J et al. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage 2011; 56: 76681.
  • 8
    Westman E, Simmons A, Muehlboeck J et al. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011b; 58: 81828.
  • 9
    Simmons A, Westman E, Muehlboeck S et al. MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci 2009; 1180: 4755.
  • 10
    Simmons A, Westman E, Muehlboeck S et al. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry 2011; 26: 7582.
  • 11
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision, Washington: American Psychiatric Association, 2000.
  • 12
    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 135664.
  • 13
    Jack CRJ, Bernstein MA, Fox NC et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008; 27:68591.
  • 14
    Fischl B, Salat DH, Busa E et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 34155.
  • 15
    Fischl B, van der Kouwe A, Destrieux C et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004; 14: 1122.
  • 16
    Han X, Fischl B. Atlas renormalization for improved brain MR image segmentation across scanner platforms. IEEE Trans Med Imaging 2007; 26: 47986.
  • 17
    Westman E, Wahlund L, Foy C et al. Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. J Alzheimers Dis 2011; 26(Suppl 3): 30719.
  • 18
    Westman E, Cavallin L, Muehlboeck J et al. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS ONE 2011a; 6: e22506.
  • 19
    Liu Y, Paajanen T, Zhang Y et al. Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups–the AddNeuroMed study. Neurobiol Aging 2011; 32: 1198206.
  • 20
    Liu Y, Paajanen T, Westman E et al. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis 2010; 21: 94766.
  • 21
    Thambisetty M, Simmons A, Velayudhan L et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 2010; 67: 73948.
  • 22
    Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wiksröm C, Wold S. Multi- and Megavariate Data Analysis (Part I -Basics and Principles and Applications), 2nd edn. Umeå: Umetrics, 2006.
  • 23
    Stenlund H, Gorzsás A, Persson P, Sundberg B, Trygg J. Orthogonal projections to latent structures discriminant analysis modeling on in situ FT-IR spectral imaging of liver tissue for identifying sources of variability. Anal Chem 2008; 80: 6898906.
  • 24
    Bylesjö M, Eriksson D, Kusano M, Moritz T, Trygg J. Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J 2007; 52: 118191.
  • 25
    Zhang D, Wang Y, Zhou L, Yuan H, Shen D. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011; 55: 85667.
  • 26
    Chu C, Hsu A, Chou K, Bandettini P, Lin C. Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage 2012; 60: 5970.
  • 27
    Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 2011; 77: 161928.
  • 28
    Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 2011; 32:2322.e1927.
  • 29
    Westman E, Muehlboeck J, Simmons A. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 2012; 62: 22938.
  • 30
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 83943.
  • 31
    Metz C, Herman B, Roe C. Statistical comparison of two roc-curve estimates obtained from partially-paired datasets. Med Decis Making 1998; 18: 11021.
  • 32
    Metz C, Kronman H. Statistical significance tests for binormal roc-curves. J Math Psychol 1980; 22: 21843.
  • 33
    Metz C, Pan X. Proper binormal roc curves: theory and maximum-likelihood estimation. J Math Psychol 1999; 43: 133.
  • 34
    Reiman EM, Jagust WJ. Brain imaging in the study of Alzheimer's disease. Neuroimage 2012; 61(2): 50516. doi: 10.1016/j.neuroimage.2011.11.075. Epub 2011 Dec 7.
  • 35
    Liu Y, Paajanen T, Westman E et al. APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord 2010; 30: 22937.
  • 36
    Jack Jr CR, Barkhof F, Bernstein MA et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dementia 2011 Jul; 7: 47485. e4. doi: 10.1016/j.jalz.2011.04.007.
  • 37
    McEvoy LK, Holland D, Hagler DJJ, Fennema-Notestine C, Brewer JB, Dale AM. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology 2011; 259: 83443.
  • 38
    Whitwell JL, Przybelski SA, Weigand SD et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007; 130: 177786.
  • 39
    Wilson RS, Bennett DA, Bienias JL et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002; 59:19104.